[Transition from pediatric to adult care: Recommendations of the French network for autoimmune and autoinflammatory diseases (FAI
La transition de la pédiatrie à l’âge adulte : recommandations de prise en charge de la filière des maladies auto-immunes et auto-inflammatoires rares FAI
Adolescent
Maladies auto-immunes
Maladies auto-inflammatoires
Maladies rares
Mare diseases
Mdolescent
Mransition
Mutoimmune diseases
Mutoinflammatory diseases
Transition
Journal
La Revue de medecine interne
ISSN: 1768-3122
Titre abrégé: Rev Med Interne
Pays: France
ID NLM: 8101383
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
22
12
2020
accepted:
07
02
2021
pubmed:
21
6
2021
medline:
25
11
2021
entrez:
20
6
2021
Statut:
ppublish
Résumé
Autoimmune and autoinflammatory diseases (AIDs) are a heterogeneous group of diseases. They can occur in childhood and account for significant morbidity and mortality. Transitioning from pediatric to adult healthcare can be difficult for patients and their families. It can interfere with patient follow-up and management, and eventually lead to complications. Although recommendations exist for the successful transition of patients with chronic diseases, few are specifically adapted to children and adults with AIDs (Suris et al., 2015-Solau-Gervais, 2012). The French working group on transition of the rare autoimmune and autoinflammatory diseases presents its reflections and recommendations for a successful transition. Preparation for transition should start early. Its goals are to empower adolescents by providing them with the knowledge to manage their own care, respond appropriately to changes in their condition, and evolve within the adult healthcare system. This requires the active participation of the patient, his or her family, as well as the pediatric and adult medical teams. The transition process involves multidisciplinary care and dedicated therapeutic education programs. Finally, the identification of medical specialists by region, trained in rare AIDs and accompanied by expert patients, may improve the management of patients with rare AIDs from adolescence to adulthood.
Identifiants
pubmed: 34147259
pii: S0248-8663(21)00028-X
doi: 10.1016/j.revmed.2021.02.003
pii:
doi:
Types de publication
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
633-638Informations de copyright
Copyright © 2021 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.